Amy Moore

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

Kathryn F. Mileham, Caroline Schenkel, Suanna S. Bruinooge et al. · Cancer Medicine · 2021 · 51 citations · Full text

Medicine, Oncology, Medical Oncology +14

The 2021 Global Lung Cancer Therapy Landscape

Dhruba Deb, Amy Moore, Upal Roy · Journal of Thoracic Oncology · 2022 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +16

Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

Navneet Singh, Nofisat Ismaila, Navneet Singh et al. · Journal of Clinical Oncology · 2024 · 36 citations

Medicine, Oncology, Thoracic Oncology +4

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable

Edward S. Kim, Upal Basu Roy, Jennifer L. Ersek et al. · Journal of Thoracic Oncology · 2019 · 22 citations

Medicine, Molecular Medicine, Oncology +14

The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer

Barbara J. Gitlitz, Silvia Novello, Tiziana Vavalà et al. · JTO Clinical and Research Reports · 2021 · 21 citations · Full text

Medicine, Genetics, Oncology +17